FDA’s Proposed Regulations Opens New US Markets FREDERICK, MD, USA, February 21, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of disposable drug-free healing pain therapy devices welcomed the FDA recommendations announced today in their Docket No. FDA-2012-N-0378, “Physical Medicine Devices; Reclassification and Renaming of Shortwave Diathermy for All Other Uses. “We are pleased … Continue Reading
BioElectronics’ Innovative Pain Relief Products Nominated for Most Innovative New OTC Product Award and Others by OTC Bulletin
FREDERICK, MD, USA, February 18, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that its ActiPatch® Musculoskeletal Pain Relief Therapy and Smart Insole™ Heel Pain Therapy products have received award nominations from the OTC Bulletin, the leading international trade publication for OTC developments worldwide. The ActiPatch® has … Continue Reading
Pain Management Medical Journal Features BioElectronics’ Innovative Pain Products Because Pain is Not a Druggable Disease
FREDERICK, MD, USA, January 9, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today the publication of feature article The Case for Over-the-Counter Shortwave Therapy: Safe and Effective Devices for Pain Management in the peer reviewed journal Pain Management (http://www.futuremedicine.com/doi/full/10.2217/pmt.13.60). The current methods of drug-based analgesia are often … Continue Reading
BioElectronics Enters the $20 Billion Dental Market
FREDERICK, MD, USA, December 30, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Pros Apac Corporation (www.pros-apac.com) based in Manila will be the exclusive dental distributor for RecoveryRx® in the Philippines. The global dental equipment and consumables market had an estimated size of US$20 billion. This … Continue Reading
BioElectronics’ ActiPatch® Musculoskeletal Pain Therapy Now Available in Boots Stores
FREDERICK, MD. December 9, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that Boots (www.boots.com), the UK‘s premiere health and beauty retailer is selling its ActiPatch® Pain Therapy products in its select stores for back, knee and musculoskeletal ailments. Paul Screawn, Director of GRO-International, European … Continue Reading
BioElectronics’ RecoveryRx® and Smart Insole™ are Now Available in Austria
30 to 60% of Patients Still Have Chronic Pain Two Months After Surgery FREDERICK, MD, USA, November 19, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Biomax, Inc. and One Globe Biotechnology LLC have joined forces with Healthcare24 (www.healthcare24.at) to exclusively distribute RecoveryRx® and Smart Insole™ … Continue Reading
BioElectronics Appoints D.E.N. Medical as Distributor for Benelux Countries
RecoveryRx® Therapy Is Reducing Post-surgical Pain and Drug Use in a Global Market of 234 Million Surgeries Annually FREDERICK, MD, USA, October 31, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that it has signed D.E.N. Medical (www.denmedical.eu) as a distributor of RecoveryRx® Therapy in the Benelux … Continue Reading
A New Audio Interview With Dr. Christine Dumas, Public Affairs Spokesperson and Patient Advocate for BioElectronics Corporation, is now at SmallCapVoice.com
AUSTIN, Texas, Oct 28, 2013 (GLOBE NEWSWIRE via COMTEX) — SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioElectronics Corporation (OTC Pink:BIEL), the maker of advanced consumer pain management medical devices, is now available. The interview can be heard at http://smallcapvoice.com/blog/10-25-13-smallcapvoice-interview-with-bioelectronics-corporation-biel Dr. Christine Dumas of BioElectronics Corporation, called into SmallCapVoice.com to go … Continue Reading
A Letter from President Andrew J. Whelan
October 24, 2013 Dear Fellow Shareholders: I want to report on the progress we’re making on the four-part growth strategy I articulated in my last letter to shareholders. I said that the path to success for BioElectronics would focus on the following four ongoing efforts: 1) Executing an aggressive marketing and sales program in the … Continue Reading
BioElectronics’ ActiPatch® Therapy Alleviates Heel Pain
Heel Pain is the leading podiatric medical complaint FREDERICK, MD, USA, October 23, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today the completion of a randomized, placebo controlled crossover trial on plantar fasciitis (heel pain) using ActiPatch®. ActiPatch uses pulsed shortwave field therapy to reduce pain, inflammation … Continue Reading